Acucela to Participate in Biotech Showcase™ 2020
SEATTLE--(BUSINESS WIRE)--Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo: 4596), announced today its participation in Biotech Showcase™ 2020, being held in San Francisco, CA, from January 13-15, 2020, in parallel with the 38th annual J.P. Morgan Healthcare Conference. The event will be attended by Jim Niebanck, Chief Commercialization Officer, and Michael Kuran, Business Development and Licensing Ad